Ph.D. Jonathan B. Rothbard - 04 Sep 2023 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role: Chief Scientific Officer
Signature: /s/ Jonathan B. Rothbard, Ph.D.
Issuer symbol: ATNF
Transactions as of: 04 Sep 2023
Net transactions value: $0
Form type: 4
Filing time: 08 Sep 2023, 16:00:34 UTC
Previous filing: 10 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ATNF	Common Stock						28,023	04 Sep 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATNF	Stock Option (Right to Buy)	Award	$0	+15,000		$0.000000	15,000	04 Sep 2023	Common Stock	15,000	$0.6700	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Stock Options were granted to the Reporting Person pursuant to the Issuer's First Amended and Restated 2022 Omnibus Incentive Plan in consideration for services to be rendered as Chief Scientific Officer. Exempt from Section 16(b) pursuant to Rule 16b-3.
F2	The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.